"Interestingly, 23andMe’s newly announced agreement with Genentech is only the first of 10 deals the company has struck with large drug and biotech companies. Such deals will utilize the database that was created by 23andMe’s customers who bought its DNA test kits and donated their health and genetic data for research.
Since 2006, 23andMe has amassed data from 800,000 customers, about 600,000 of whom have agreed that their genetic data will be used for research purposes. The deal, however, also appears to prove what journalist Charles Seife has long suspected to be the true intentions of 23andMe.
“The Personal Genome Service isn’t primarily intended to be a medical device,” Seife wrote in the Scientific American in November 2013. “It is a mechanism meant to be a front end for a massive information-gathering operation against an unwitting public.”
http:// www.renegadetribune.com/the-jews-behind-23andme-and-family-tree-dna/